117 related articles for article (PubMed ID: 15567486)
41. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
42. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease.
Gastard MC; Troncoso JC; Koliatsos VE
Ann Neurol; 2003 Sep; 54(3):393-8. PubMed ID: 12953274
[TBL] [Abstract][Full Text] [Related]
43. X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.
Ikonomovic MD; Abrahamson EE; Isanski BA; Debnath ML; Mathis CA; Dekosky ST; Klunk WE
Methods Enzymol; 2006; 412():123-44. PubMed ID: 17046656
[TBL] [Abstract][Full Text] [Related]
44. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
Jeynes B; Provias J
Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
[TBL] [Abstract][Full Text] [Related]
45. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
46. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H;
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444
[TBL] [Abstract][Full Text] [Related]
47. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
48. Factors determining the size frequency distribution of beta-amyloid (A beta) deposits in Alzheimer's disease.
Armstrong RA; Myers D; Smith CU
Exp Neurol; 1997 Jun; 145(2 Pt 1):574-9. PubMed ID: 9217093
[TBL] [Abstract][Full Text] [Related]
49. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
Sudo S; Shiozawa M; Cairns NJ; Wada Y
J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688
[TBL] [Abstract][Full Text] [Related]
50. Aluminum in hippocampal neurons from humans with Alzheimer's disease.
Walton JR
Neurotoxicology; 2006 May; 27(3):385-94. PubMed ID: 16458972
[TBL] [Abstract][Full Text] [Related]
51. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
53. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
[TBL] [Abstract][Full Text] [Related]
54. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow RH
Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
[TBL] [Abstract][Full Text] [Related]
55. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease.
von Gunten A; Kövari E; Bussière T; Rivara CB; Gold G; Bouras C; Hof PR; Giannakopoulos P
Neurobiol Aging; 2006 Feb; 27(2):270-7. PubMed ID: 16399212
[TBL] [Abstract][Full Text] [Related]
56. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
57. The amyloid cascade hypothesis.
Korczyn AD
Alzheimers Dement; 2008 May; 4(3):176-8. PubMed ID: 18631966
[TBL] [Abstract][Full Text] [Related]
58. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
59. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
60. An immunohistochemical study of GABA A receptor gamma subunits in Alzheimer's disease hippocampus: relationship to neurofibrillary tangle progression.
Iwakiri M; Mizukami K; Ikonomovic MD; Ishikawa M; Abrahamson EE; DeKosky ST; Asada T
Neuropathology; 2009 Jun; 29(3):263-9. PubMed ID: 19019179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
